Alcolase

Alcolase is a Danish biotech startup developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream. This technology is specifically aimed at individuals with ALDH2 deficiency, a genetic variant common in East Asia that impairs alcohol metabolism, leading to adverse reactions and increased health risks. The company's proprietary encapsulation technology protects enzymes from stomach acid, allowing them to remain active in the stomach. Alcolase plans to initially target markets in Singapore and South Korea, with a long-term vision of creating healthier alternatives within global drinking culture and exploring broader therapeutic use-cases through its UK subsidiary.